Overview

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Rheumatoid arthritis (RA) is a chronic and disabling disease. tumor necrosis factor-a(TNF-a) inhibitors have demonstrated an outstanding performance in relieving joint inflammation and retarding bone erosion involved in RA. However, there is still about one-thirds of RA patients had a poor response to TNF α inhibitors. The Investigators hope to discover prediction protein with a domestic genetic background and finally establish prediction system with Chinese characteristics.
Phase:
Phase 4
Details
Lead Sponsor:
Fen Li
Treatments:
Adalimumab
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Etanercept
Glucocorticoids
Infliximab
Leflunomide
Methotrexate
Methylprednisolone
Prednisone